Archives for January 13, 2016

update

Better data can encourage industry to trial generics for new indications

Higher quality data could convince pharma firms to pay to trial generic drugs for new indications say researchers calling for diclofenac to be studied as a cancer treatment.

More takeovers: Eurofins buys pharma QC services firm Sinensis Life Science

Eurofins Scientific has bought drug quality control testing firm Sinensis Life Science BV in a move designed to expand its global reach.

Pfizer, HemoShear collaboration to create new 'safety paradigm'

HemoShear Therapeutics has teamed up with Pfizer to develop a predictive model for preclinical drug-induced vascular injury (DIVI).

Pfizer and Allergan to mull splitting up again in 2018 say CEOs

The Pfizer-Allergan $160bn merger will create the world’s largest pharma company but potentially not for long, as the two CEOs discuss breaking the entity up in 2018.

Survey: M&A drivers, inhibitors in 2016

As the industry faces new challenges in 2016, the pharmaceutical industry is expected to be the second busiest sector for consolidation with large cash reserves driving deals, according to experts.